Glycosylated Porphyrins, Phthalocyanines, and Other Porphyrinoids for Diagnostics and Therapeutics.
Ontology highlight
ABSTRACT:
SUBMITTER: Singh S
PROVIDER: S-EPMC6011754 | biostudies-literature | 2015 Sep
REPOSITORIES: biostudies-literature
Publications
Glycosylated Porphyrins, Phthalocyanines, and Other Porphyrinoids for Diagnostics and Therapeutics.
Singh Sunaina S Aggarwal Amit A Bhupathiraju N V S Dinesh K NV Arianna Gianluca G Tiwari Kirran K Drain Charles Michael CM
Chemical reviews 20150828 18
Similar Datasets
Project description:The large area scalable fabrication of supported porous metal and metal oxide nanomaterials is acknowledged as one of the greatest challenges for their eventual implementation in on-device applications. In this work, we will present a comprehensive revision and the latest results regarding the pioneering use of commercially available metal phthalocyanines and porphyrins as solid precursors for the plasma-assisted deposition of porous metal and metal oxide films and three-dimensional nanostructures (hierarchical nanowires and nanotubes). The most advanced features of this method relay on its ample general character from the point of view of the porous material composition and microstructure, mild deposition and processing temperature and energy constrictions and, finally, its straightforward compatibility with the direct deposition of the porous nanomaterials on processable substrates and device-architectures. Thus, taking advantage of the variety in the composition of commercially available metal porphyrins and phthalocyanines, we present the development of metal and metal oxides layers including Pt, CuO, Fe2O3, TiO2, and ZnO with morphologies ranging from nanoparticles to nanocolumnar films. In addition, we combine this method with the fabrication by low-pressure vapor transport of single-crystalline organic nanowires for the formation of hierarchical hybrid organic@metal/metal-oxide and @metal/metal-oxide nanotubes. We carry out a thorough characterization of the films and nanowires using SEM, TEM, FIB 3D, and electron tomography. The latest two techniques are revealed as critical for the elucidation of the inner porosity of the layers.
| S-EPMC7311806 | biostudies-literature
Project description:In continuation of our work on glycoconjugated phthalocyanines, two new water soluble, non-ionic zinc(II) phthalocyanines have been prepared and fully characterized by means of ¹H-NMR, 13C-NMR, MALDI-TOF, ESI-TOF, UV-Vis spectroscopy, emission spectroscopy and fluorescence lifetime measurements. The carbohydrate-containing phthalonitrile precursors were synthesized through a copper-catalyzed azide-alkyne cycloaddition (CuAAC). The 2-methoxyethoxymethyl protecting group (MEM) was used to protect the carbohydrate moieties. It resisted the harsh basic cyclotetramerization conditions and could be easily cleaved under mild acidic conditions. The glycoconjugated zinc(II) phthalocyanines described here have molar extinction coefficents εmax>10⁵ m(-1) cm(-1) and absorption maxima λ>680 nm, which make them attractive photosensitizers for photo-dynamic therapy.
| S-EPMC6332196 | biostudies-literature
Project description:The development of novel synthetic methods has greatly expanded the toolbox available to chemists for engineering porphyrin and phthalocyanine derivatives with precise electronic and optical properties. In this study, we focus on the UV-vis absorption characteristics of substituted phthalocyanines and their contracted analogs, subphthalocyanines, which feature nonplanar, bowl-shaped geometries. These macrocycles, which are central to numerous applications in materials science and catalysis, possess extensive π-conjugated systems that drive their unique electronic properties. We explore how the change from a metalloid (B) to a metal (Zn) and the resulting coordination environments influence the aromaticity and, consequently, the spectroscopic features of these systems. A combined computational and experimental approach reveals a direct correlation between the aromaticity of the external conjugated pathways and the Q bands in the UV-vis spectra. Our findings highlight key structural modifications that can be leveraged to fine-tune the optical properties of porphyrinoid systems, offering new pathways for the design of advanced materials and catalysts with tailored functionalities.
| S-EPMC11465665 | biostudies-literature
Project description:We combined a conducting polymer, polyaniline (PANI), with an organic semiconducting macrocyclic (MCs) material. The macrocycles are the phthalocyanines and porphyrins used to tune the electrical properties of the PANI, which benefits from their ability to enhance sensor response. For this, we proceeded by a simple ultrasonically assisted reaction involving the two components, i.e., the PANI matrix and the MCs, to achieve the synthesis of the composite nanostructure PANI/MCs. The composite nanostructure has been characterized and deposited on interdigitated electrodes (IDEs) to construct resistive sensor devices. The isolated nanostructured composites present good electrical properties dominated by PANI electronic conductivity, and the characterization reveals that both components are present in the nanostructure. The experimental results obtained under gas exposures show that the composite nanostructures can be used as a sensing material with enhanced sensing properties. The sensing performance under different conditions, such as ambient humidity, and the sensor's operating temperature are also investigated. Sensing behavior in deficient humidity levels and their response at different temperatures revealed unusual behaviors that help to understand the sensing mechanism. Gas sensors based on PANI/MCs demonstrate significant stability over time, but this stability is highly reduced after experiments in lower humidity conditions and at high temperatures.
| S-EPMC8912817 | biostudies-literature
Project description:The proto-oncogene ROS1 encodes a receptor tyrosine kinase with an unknown physiological role in humans. Somatic chromosomal fusions involving ROS1 produce chimeric oncoproteins that drive a diverse range of cancers in adult and paediatric patients. ROS1-directed tyrosine kinase inhibitors (TKIs) are therapeutically active against these cancers, although only early-generation multikinase inhibitors have been granted regulatory approval, specifically for the treatment of ROS1 fusion-positive non-small-cell lung cancers; histology-agnostic approvals have yet to be granted. Intrinsic or extrinsic mechanisms of resistance to ROS1 TKIs can emerge in patients. Potential factors that influence resistance acquisition include the subcellular localization of the particular ROS1 oncoprotein and the TKI properties such as the preferential kinase conformation engaged and the spectrum of targets beyond ROS1. Importantly, the polyclonal nature of resistance remains underexplored. Higher-affinity next-generation ROS1 TKIs developed to have improved intracranial activity and to mitigate ROS1-intrinsic resistance mechanisms have demonstrated clinical efficacy in these regards, thus highlighting the utility of sequential ROS1 TKI therapy. Selective ROS1 inhibitors have yet to be developed, and thus the specific adverse effects of ROS1 inhibition cannot be deconvoluted from the toxicity profiles of the available multikinase inhibitors. Herein, we discuss the non-malignant and malignant biology of ROS1, the diagnostic challenges that ROS1 fusions present and the strategies to target ROS1 fusion proteins in both treatment-naive and acquired-resistance settings.
| S-EPMC8830365 | biostudies-literature
Project description:Aptamers are short single-stranded DNA or RNA oligonucleotides that can selectively bind to small molecular ligands or protein targets with high affinity and specificity, by acquiring unique three-dimensional structures. Aptamers have the advantage of being highly specific, relatively small in size, non-immunogenic and can be easily stabilized by chemical modifications, thus allowing expansion of their diagnostic and therapeutic potential. Since the invention of aptamers in the early 1990s, great efforts have been made to make them clinically relevant for diseases like macular degeneration, cancer, thrombosis and inflammatory diseases. Furthermore, owing to the aforementioned advantages and unique adaptability of aptamers to point-of-care platforms, aptamer technology has created a stable niche in the field of in vitro diagnostics by enhancing the speed and accuracy of diagnoses. The aim of this review is to give an overview on aptamers, highlight the inherent therapeutic and diagnostic opportunities and challenges associated with them and present various aptamers that have reached therapeutic clinical trials, diagnostic markets or that have immediate translational potential for therapeutics and diagnostics applications.
| S-EPMC6096388 | biostudies-literature
Project description:This review describes the state of the art in nanoparticle and nanodevice applications for medical diagnosis and disease treatment. Nanodevices, such as cantilevers, have been integrated into high-sensitivity disease marker diagnostic detectors and devices, are stable over long periods of time, and display reliable performance properties. Nanotechnology strategies have been applied to therapeutic purposes as well. For example, nanoparticle-based delivery systems have been developed to protect drugs from degradation, thereby reducing the required dose and dose frequency, improving patient comfort and convenience during treatment, and reducing treatment expenses. The main objectives for integrating nanotechnologies into diagnostic and therapeutic applications in the context of intestinal diseases are reviewed.
| S-EPMC3970315 | biostudies-other
Project description:Small molecules with modalities for a variety of imaging techniques as well as therapeutic activity are essential, as such molecules render opportunities to simultaneously conduct diagnosis and targeted therapy, so called theranostics. In this regard, glycoporphyrins have proven useful as theranostic agents towards cancer, as well as noncancerous conditions. Herein, the synthesis and characterization of heterobifunctional glycoconjugated porphyrins with two different sugar moieties, a common monosaccharide at three sites, and a 2-fluoro-2-deoxy glucose (FDG) moiety at the fourth site are presented. The fluoro-glycoconjugated porphyrins exhibit properties for multimodal imaging and photodynamic therapy, as well as specificity towards cancer cells. We foresee that our findings might aid in the chemical design of heterobifunctional glycoconjugated porphyrins that could be utilized as theranostic agents.
| S-EPMC6031858 | biostudies-literature
Project description:A series of different singlet oxygen photosensitizers was immobilized onto nanoporous gold powder with a mean pore size of 40 nm via copper catalyzed azide-alkyne cycloaddition. The attachment of phthalocyanine and porphyrin derivatives was performed on the peripheral substituent of the macrocycle, whereas the subphthalocyanine derivatives were attached via the axial substituent with respect to the macrocyclic ring system. All obtained hybrid systems were studied in the photooxidation of 2,5-diphenylfuran as a chemical singlet oxygen quencher and showed increased photocatalytic activity compared to the same amount of the corresponding photosensitizer in solution due to photoinduced interactions of the plasmon resonance of the nanostructured gold support and the attached photosensitizer. The understanding of the different photophysical interactions depending on the coordination mode of the macrocycle as well as the position of the absorbance in the electromagnetic spectrum is an important point in the development towards highly active hybrid photocatalysts covering a broad absorption range within the spectrum of visible light.
| S-EPMC8695993 | biostudies-literature
Project description:There is a need to identify effective biomarkers for diagnosis, prognosis and prediction of treatment efficacy for many liver diseases such as hepatocellular cancer, and chronic viral hepatitis. The identification of disease-specific alterations in microRNA expression and the ability to detect microRNAs in the circulation provide the basis for identifying novel clinically effective treatments and biomarkers. Knowledge regarding miRNA in human liver disease may eventually lead to serum or tissue biomarkers with clinical utility. A selection of relevant studies is reviewed. There are major challenges that need to be addressed prior to clinical application such as the need for careful validation of diagnostic miRNA candidates in well described clinical cohorts, and technical issues such as quantitation and standardization of assays. The rapid progress in therapeutic interventions using miRNA based strategies for chronic hepatitis C and hepatocellular cancer provides optimism for novel approaches that will build on the existing and emerging knowledge regarding miRNA in liver diseases.
| S-EPMC3804836 | biostudies-literature